LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) Stock Cash Flow
USA - NASDAQ:LIXT - US5393193017 - Common Stock
4.43 USD
+0.14 (+3.26%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -3.09M | -3.59M | -5.09M | -6.31M | -6.73M | |||
| Change In Working Capital | -75.90K | 3.00K | 20.60K | 150.00K | -10.00K | |||
| Interest Paid | 10.50K | 16.80K | 16.20K | 10.00K | 10.00K | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Other non cash items | 552.50K | 418.40K | 773.20K | 1.55M | 2.60M | |||
| OPERATING CASH FLOW | -2.61M | -3.16M | -4.29M | -4.61M | -4.14M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Other Investing Activity | N/A | N/A | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | N/A | N/A | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | N/A | 0.00 | 3.14M | 5.14M | 3.91M | |||
| Dividend Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other Financing Activity | N/A | N/A | N/A | 0.00 | -10.00K | |||
| FINANCING CASH FLOW | N/A | 0.00 | 3.14M | 5.14M | 3.90M | |||
| CHANGE IN CASH | -1.71M | -3.16M | -1.15M | 530.00K | -250.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -2.61M | -3.16M | -4.29M | -4.61M | -4.14M | |||
| FREE CASH FLOW | -2.61M | -3.16M | -4.29M | -4.61M | -4.14M | |||
All data in USD